Sign In

Login

Password

Forgot Password ? Sign Up

Layşmanyaz (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Layşmanyaz" in Turkish language version.

refsWebsite
Global rank Turkish rank
6doi.org
2nd place
4th place
6nih.gov
4th place
11th place
2who.int
195th place
162nd place
2web.archive.org
1st place
1st place

doi.org

  • Barrett, MP; Croft, SL (2012). "Management of trypanosomiasis and leishmaniasis". British Medical Bulletin. Cilt 104. ss. 175-96. doi:10.1093/bmb/lds031. PMC 3530408 $2. PMID 23137768. 
  • Sundar, S; Chakravarty, J (Jan 2013). "Leishmaniasis: an update of current pharmacotherapy". Expert opinion on pharmacotherapy. 14 (1). ss. 53-63. doi:10.1517/14656566.2013.755515. PMID 23256501. 
  • Dorlo, TP; Balasegaram, M; Beijnen, JH; de Vries, PJ (Nov 2012). "Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis". The Journal of antimicrobial chemotherapy. 67 (11). ss. 2576-97. doi:10.1093/jac/dks275. PMID 22833634. 
  • Minodier, P; Parola, P (Mayıs 2007). "Cutaneous leishmaniasis treatment". Travel medicine and infectious disease. 5 (3). ss. 150-8. doi:10.1016/j.tmaid.2006.09.004. PMID 17448941. 
  • Lozano, R (15 Aralık 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859). ss. 2095-128. doi:10.1016/S0140-6736(12)61728-0. PMID 23245604. 
  • Ejazi, SA; Ali, N (Jan 2013). "Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects". Expert review of anti-infective therapy. 11 (1). ss. 79-98. doi:10.1586/eri.12.148. PMID 23428104. 

nih.gov

ncbi.nlm.nih.gov

  • Barrett, MP; Croft, SL (2012). "Management of trypanosomiasis and leishmaniasis". British Medical Bulletin. Cilt 104. ss. 175-96. doi:10.1093/bmb/lds031. PMC 3530408 $2. PMID 23137768. 
  • Sundar, S; Chakravarty, J (Jan 2013). "Leishmaniasis: an update of current pharmacotherapy". Expert opinion on pharmacotherapy. 14 (1). ss. 53-63. doi:10.1517/14656566.2013.755515. PMID 23256501. 
  • Dorlo, TP; Balasegaram, M; Beijnen, JH; de Vries, PJ (Nov 2012). "Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis". The Journal of antimicrobial chemotherapy. 67 (11). ss. 2576-97. doi:10.1093/jac/dks275. PMID 22833634. 
  • Minodier, P; Parola, P (Mayıs 2007). "Cutaneous leishmaniasis treatment". Travel medicine and infectious disease. 5 (3). ss. 150-8. doi:10.1016/j.tmaid.2006.09.004. PMID 17448941. 
  • Lozano, R (15 Aralık 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859). ss. 2095-128. doi:10.1016/S0140-6736(12)61728-0. PMID 23245604. 
  • Ejazi, SA; Ali, N (Jan 2013). "Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects". Expert review of anti-infective therapy. 11 (1). ss. 79-98. doi:10.1586/eri.12.148. PMID 23428104. 

web.archive.org

who.int